Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 885-891, August 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, K. E.
Right arrow Articles by Siminoff, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, K. E.
Right arrow Articles by Siminoff, P.

A Comparison of the in Vitro Susceptibility of HeLa and Protozoan Cells to Antitumor Antibiotics*

K. E. Price, R. E. Buck, A. Schlein and P. Siminoff

( Research Division, Bristol Laboratories, Syracuse, New York)

The relative in vitro susceptibility of HeLa cells and three protozoan species to a number of fermentation-derived materials was determined. Of the 61 purified agents tested in tube dilution and plate diffusion tests, 35 had displayed antitumor activity in rodents. The test system found to be most sensitive to the antitumor agents was that employing HeLa cells. Among the protozoan species, the descending order of sensitivity to tumor-active agents was as follows: Tetrahymena pyriformis, Ochromonas malhamensis, and Crithidia fasciculata. This order was not maintained in tests with the 26 tumor-inactive agents, since O. malhamensis showed the greatest susceptibility and C. fasciculata the least, while HeLa cells and T. pyriformis were intermediate. In tests with tumor-active and tumor-inactive fermentation beers, the HeLa test system very effectively distinguished between them, whereas all the protozoan species proved to be relatively poor detectors of beer antitumor agents.

* This investigation was supported in part by Cancer Chemotherapy National Service Center Contract No. Sa-43-ph-4362, National Cancer Institute, National Institutes of Health.

Received 4/23/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.